EP1750767A4 - Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren - Google Patents

Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren

Info

Publication number
EP1750767A4
EP1750767A4 EP05755940A EP05755940A EP1750767A4 EP 1750767 A4 EP1750767 A4 EP 1750767A4 EP 05755940 A EP05755940 A EP 05755940A EP 05755940 A EP05755940 A EP 05755940A EP 1750767 A4 EP1750767 A4 EP 1750767A4
Authority
EP
European Patent Office
Prior art keywords
making
methods
pharmaceutical formulations
acid secretion
formulations useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05755940A
Other languages
English (en)
French (fr)
Other versions
EP1750767A1 (de
Inventor
Kay Olmstead
Warren Hall
Gerald T Proehl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santarus Inc
Original Assignee
Santarus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santarus Inc filed Critical Santarus Inc
Publication of EP1750767A1 publication Critical patent/EP1750767A1/de
Publication of EP1750767A4 publication Critical patent/EP1750767A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP05755940A 2004-05-25 2005-05-25 Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren Withdrawn EP1750767A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57464604P 2004-05-25 2004-05-25
US57466304P 2004-05-25 2004-05-25
PCT/US2005/018585 WO2005115474A1 (en) 2004-05-25 2005-05-25 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Publications (2)

Publication Number Publication Date
EP1750767A1 EP1750767A1 (de) 2007-02-14
EP1750767A4 true EP1750767A4 (de) 2010-09-22

Family

ID=35450661

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05755940A Withdrawn EP1750767A4 (de) 2004-05-25 2005-05-25 Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren

Country Status (5)

Country Link
EP (1) EP1750767A4 (de)
JP (1) JP2008500365A (de)
CA (1) CA2566655C (de)
MX (1) MXPA06013585A (de)
WO (1) WO2005115474A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2665226C (en) * 2006-10-05 2014-05-13 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
KR101908748B1 (ko) * 2010-12-03 2018-10-16 다케다 야쿠힌 고교 가부시키가이샤 구강내 붕괴정
JP6641626B2 (ja) * 2015-12-25 2020-02-05 エスエス製薬株式会社 制酸用医薬組成物
KR102080023B1 (ko) 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR102006777B1 (ko) * 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
MX2021001905A (es) * 2018-08-23 2021-04-28 Chong Kun Dang Pharmaceutical Corp Preparacion farmaceutica que tiene excelentes propiedades de disolucion, que contiene esomeprazol y bicarbonato de sodio.
JP2022541948A (ja) * 2019-07-26 2022-09-28 チョン クン ダン ファーマシューティカル コーポレイション エソメプラゾール及び炭酸水素ナトリウムを含む安定した薬学的組成物
KR102573842B1 (ko) * 2020-02-21 2023-09-01 주식회사 종근당 방출특성이 우수한 에스오메프라졸 및 탄산수소나트륨의 약제학적 조성물

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002098352A2 (en) * 2001-06-01 2002-12-12 Pozen Inc. PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
WO2003009846A1 (en) * 2001-07-09 2003-02-06 Curators Of The University Of Missouri Novel substituted benzimidazole dosage forms and method of using same
US20040058018A1 (en) * 1996-01-04 2004-03-25 The Curators Of The University Of Missouri Novel substituted benzimidazole dosage forms and method of using same
WO2005007115A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
WO2005076987A2 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
WO2005117870A2 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5622719A (en) 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040058018A1 (en) * 1996-01-04 2004-03-25 The Curators Of The University Of Missouri Novel substituted benzimidazole dosage forms and method of using same
WO2002098352A2 (en) * 2001-06-01 2002-12-12 Pozen Inc. PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
WO2003009846A1 (en) * 2001-07-09 2003-02-06 Curators Of The University Of Missouri Novel substituted benzimidazole dosage forms and method of using same
WO2005007115A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
WO2005076987A2 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
WO2005117870A2 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2005115474A1 *

Also Published As

Publication number Publication date
CA2566655A1 (en) 2005-12-08
MXPA06013585A (es) 2009-07-22
JP2008500365A (ja) 2008-01-10
CA2566655C (en) 2013-04-16
WO2005115474A1 (en) 2005-12-08
WO2005115474B1 (en) 2006-02-23
EP1750767A1 (de) 2007-02-14

Similar Documents

Publication Publication Date Title
EP1648416A4 (de) Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren
IL177566A0 (en) Pharmaceutical formulations
HK1120421A1 (en) Compositions and their preparation methods for inhibiting gastric acid secretion
GB0426301D0 (en) Pharmaceutical formulations
HK1107271A1 (en) Method of enhancing absorptions of transmucosal administration formulations
HK1119951A1 (en) Methods and compositions for oral administration of proteins
IL184735A0 (en) Pharmaceutical formulations and methods of use
HK1156311A1 (en) Preparation of pyridonecarboxylic acid antibacterials
EP1773369A4 (de) Pharmazeutische zusammensetzungen und verfahren für die peptidbehandlung
EP1750767A4 (de) Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren
IL183986A0 (en) Pharmaceutical compounds and compositions
HK1113308A1 (en) Pharmaceutical formulations of gallium salts
EP1811967A4 (de) Verfahren und formulierungen zur herstellung von pharmazeutischen zusammensetzungen mit bupropion
EP1753405A4 (de) Pharmazeutische formulierung mit kontrollierter freisetzung
EP1765373A4 (de) Ozonisierte pharmazeutische zusammensetzungen und verfahren
PL1791530T3 (pl) Kompozycja farmaceutyczna zawierająca psychostymulant
GB0404327D0 (en) Pharmaceutical composition and method of using same
EP1851739A4 (de) Pharmazeutische xanthurensäurederivatzusammensetzungen und verwandte verfahren
EP1858841A4 (de) W-alkoxyperoxycarbonsäure enthaltende zusammensetzung zur sterilisation
IL183702A0 (en) Difluoronucleosides and process for preparation thereof
GB0423800D0 (en) New pharmaceutical formulations
HK1105358A1 (en) Solid pharmaceutical formulation
EP1879013A4 (de) Verfahren zur konstruktion selbstemulgierender arzneistofformulierungen
GB0406048D0 (en) Drug formulations
ZA200706110B (en) Pharmaceutical formulations of gallium salts

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061204

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100819

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101ALI20100813BHEP

Ipc: A61K 47/00 20060101AFI20051212BHEP

Ipc: A61K 9/48 20060101ALI20100813BHEP

17Q First examination report despatched

Effective date: 20110322

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20151102